SOURCE: Dynavax Technologies

Dynavax Technologies

February 14, 2012 09:00 ET

Dynavax to Present at Two Upcoming Investor Healthcare Conferences

BERKELEY, CA--(Marketwire - Feb 14, 2012) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that Dino Dina, M.D., Chief Executive Officer, will be presenting at the Citigroup 2012 Global Health Care Conference to be held February 27-29, and at the Cowen and Company 32nd Annual Health Care Conference being held March 5-7, 2012.

Event: Citigroup 2012 Global Health Care Conference
Date: Tuesday, February 28, 2012
Time: 8:30 AM (ET)
Place: Waldorf Astoria, New York, NY

Event: Cowen and Company 32nd Annual Health Care Conference
Date: Tuesday, March 6, 2012
Time: 10:00 AM (ET)
Place: The Boston Marriott Copley Place, Boston, MA

To access the live webcast and the subsequent archived recording of the presentations, please log onto Dynavax's website at http://investors.dynavax.com/newsevents.cfm.

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and superior protection with fewer doses than current licensed vaccines. For more information visit www.dynavax.com.

Contact Information

  • Contact:
    Jennifer Lew
    Vice President, Finance
    510-665-7217
    Email Contact